EVALUATION OF IMMUNE PARAMETERS AND LYMPHOCYTE-PRODUCTION OF PROLACTIN-IMMUNOREACTIVE PROTEINS AFTER CHRONIC ADMINISTRATION OF COCAINE TO PREGNANT RATS
Sa. Masten et al., EVALUATION OF IMMUNE PARAMETERS AND LYMPHOCYTE-PRODUCTION OF PROLACTIN-IMMUNOREACTIVE PROTEINS AFTER CHRONIC ADMINISTRATION OF COCAINE TO PREGNANT RATS, The Journal of pharmacology and experimental therapeutics, 277(2), 1996, pp. 1090-1096
This study examined the effect of chronic cocaine exposure on selected
immune parameters in pregnant rats. Cocaine hydrochloride, 60 mg/kg,
was administered by i.p. injection as a divided daily dose on gestatio
n days 8 to 19. This cocaine treatment regimen did not result in any c
hange in maternal body weight, spleen and thymus body weight ratios or
lymphocyte recovery from these organs. Cocaine treatment had no effec
t on the plasma levels of prolactin, growth hormone and insulin-like g
rowth factor-1; hormones with immunoregulatory potential. In contrast,
the plasma immunoglobulin G concentration in cocaine-treated animals
was 48% higher (P < .05) than in control animals. Spleen lymphocytes a
nd thymocytes were isolated and evaluated for their proliferative resp
onses in vitro to a panel of T and B cell mitogens. Lymphocytes from c
ocaine-treated animals showed no significant differences in proliferat
ive responses to concanavalin A (conA), phytohemagglutinin, pokeweed m
itogen, interleukin-2 or lipopolysaccharide. The ability of conA-stimu
lated spleen lymphocytes to synthesize and secrete prolactin-immunorea
ctive proteins was further assessed by Western immunoblotting. We foun
d that conA-stimulated spleen lymphocytes from cocaine-treated animals
showed significantly decreased levels of intracellular and secreted 4
4,000-mw prolactin-immunoreactive proteins. In contrast, conA-stimulat
ed spleen lymphocytes from control and cocaine-treated groups secreted
equivalent amounts of the cytokine interleukin-2. In conclusion, chro
nic administration of cocaine to female rats during pregnancy signific
antly altered serum immunoglobulin G levels and lymphocyte production
of prolactin-immunoreactive proteins in the absence of changes in lymp
hocyte proliferation in response to mitogens.